Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D86ALC
|
|||
| Drug Name |
SBX-101
|
|||
| Indication | Intestinal toxicities from therapy [ICD-11: DA94.1 ] | Preclinical | [1] | |
| Company |
Symberix
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Bacterial Beta-glucuronidase (Bact uidA) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Microbiome therapeutics go small molecule. Nat Rev Drug Discov. 2019 Jul;18(8):569-572. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.